Management

 

Philippe Verwaerde,PhD CEO, CSO

18 years of international experience as manager in Pharma and Biotech R&D, cofounder (Vivactis, iNovacia)

Stéphane Burlet, PhD

Medicinal chemist

Cecilia Estrella, PhD

Neurobiologist

Annick Wattez

CFO

Founders

André Delacourte

PhD, founder : Research Director, Inserm U837, Lille. Neurobiologist, pioneer in the molecular characterization of the most common neurodegenerating processes: tauopathies, amyloidopathies and synucleopathies. 250 international publications, 4 patents in the field of diagnosis or treatment of AD.

Patricia Melnyk

PhD, founder : Pr of Chemistry, University of Lille II.15 years experience in combinatorial and medicinal chemistry. Head of a team of 12 chemists at the university, co- inventor of AD patent, experience in Biotech at Cerep.

Board

Philippe Verwaerde, Président
Christian Sergheraert, Président Université Lille 2
Hélène Cannard-Guillon, Inovam
Philippe Moons, Finorpa